𝔖 Bobbio Scriptorium
✦   LIBER   ✦

The efficacy of temozolomide for recurrent glioblastoma multiforme

✍ Scribed by Chao Chen; Tao Xu; Yicheng Lu; Juxiang Chen; Shenhong Wu

Book ID
115236460
Publisher
John Wiley and Sons
Year
2012
Tongue
English
Weight
663 KB
Volume
20
Category
Article
ISSN
1351-5101

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Salvage chemotherapy with cyclophosphami
Salvage chemotherapy with cyclophosphamide for recurrent, temozolomide-refractory glioblastoma multiforme
✍ Marc C. Chamberlain; Denice D. Tsao-Wei πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 English βš– 95 KB

## Abstract ## BACKGROUND The primary objective of the current prospective Phase II study of cyclophosphamide (CYC) in adult patients with recurrent, temozolomide‐refractory glioblastoma multiforme was to evaluate 6‐month progression‐free survival (PFS). ## METHODS Forty patients (28 men and 12

Bevacizumab and daily temozolomide for r
Bevacizumab and daily temozolomide for recurrent glioblastoma
✍ Annick Desjardins; David A. Reardon; April Coan; Jennifer Marcello; James E. Her πŸ“‚ Article πŸ“… 2011 πŸ› John Wiley and Sons 🌐 English βš– 1021 KB

## Abstract ## BACKGROUND: The authors performed a phase 2 trial of combined protracted daily temozolomide and biweekly bevacizumab for patients with recurrent glioblastoma who had previously received radiation therapy and temozolomide. ## METHODS: There was no limit on the number of previous di